Drug delivery, disposition and dynamics (D4)
Monash University has received $5 million from the Victorian Government to manufacture the first Australian batch of a COVID-19 mRNA vaccine for clinical trials, using a vaccine candidate developed by researchers from the Monash Institute of
In a critical step towards addressing an urgent unmet medical need due to infections caused by antibiotic-resistant bacteria - also known as ‘superbugs’ - a new antibiotic (QPX9003) discovered by Monash University researchers has entered
A world-leading team of antimalarial researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) have discovered a new class of molecules capable of killing Plasmodium falciparum, the parasite that causes malaria in humans through the
Professor Jonathan Baell and colleagues from WEHI were recognised for their work in developing a new cancer treatment.
A new international study led by Monash University has found that residents with type 2 diabetes in residential aged care are potentially being overtreated – or missing out on treatment altogether.
A team of researchers, led by the Monash Institute of Pharmaceutical Sciences (MIPS) have, for the first time, developed a tool that will enable the wider scientific community to gain a deeper understanding of how the human adenosine A1 receptor
A team of researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and the Murdoch Children’s Research Institute (MCRI) have collaborated to develop novel small molecules with the aim to protect heart muscle cells from
Professor Arthur Christopoulos, Dean of Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, has been elected a Fellow of the Australian Academy of Science (FAA) for his ground-breaking research and outstanding contributions to